Hemorrhagic fever viruses as biological weapons: medical and public health management.

By L. Borio, T. Inglesby, C. Peters, A. Schmaljohn, J. Hughes, P. Jahrling, T. Ksiazek, K. Johnson, A. Meyerhoff, T. O'Toole and 16 more. Journal of the American Medical Association (JAMA), 2002

681 citations recorded by the source corpus.

Subfields: Emergency Medical Services, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/1fe63287bf263589b0892ac8bcd9695e61ccb7fe

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Infectious Diseases

1. L. Chiarello
2. J. Siegel
3. M. Jackson
4. E. Rhinehart

Citations in the corpus

• Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. (2003, neutral): “Alanine aminotransferase, U/L 29 (19-49) 30 (21-67) .”
• DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells (2003, background): “Recent public health concerns also extend to the potential use of the viruses that cause hemorrhagic fevers as weaponzied biological agents (37, 38).”
• 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings (2007, methodology): “Among the more commonly known HFVs are Ebola and Marburg viruses (Filoviridae), Lassa virus (Arenaviridae), CrimeanCongo hemorrhagic fever and Rift Valley Fever virus (Bunyaviridae), and Dengue and Yellow fever viruses (Flaviviridae).(212,296) These viruses are transmitted to humans through contact ”